AMERICAN VANGUARD CORP (AVD)

US0303711081 - Common Stock

4.35  0 (0%)

After market: 4.52 +0.17 (+3.91%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AVD. AVD was compared to 83 industry peers in the Chemicals industry. AVD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AVD has a valuation in line with the averages, but it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year AVD has reported negative net income.
In the past year AVD had a positive cash flow from operations.
In the past 5 years AVD has always been profitable.
Of the past 5 years AVD 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -3.81%, AVD is not doing good in the industry: 75.90% of the companies in the same industry are doing better.
AVD has a Return On Equity of -8.82%. This is in the lower half of the industry: AVD underperforms 75.90% of its industry peers.
Industry RankSector Rank
ROA -3.81%
ROE -8.82%
ROIC N/A
ROA(3y)2.48%
ROA(5y)2.34%
ROE(3y)4.81%
ROE(5y)4.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of AVD has declined.
In the last couple of years the Operating Margin of AVD has declined.
The Gross Margin of AVD (27.46%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AVD has declined.
AVD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.46%
OM growth 3Y1.8%
OM growth 5Y-13.38%
PM growth 3Y-26.84%
PM growth 5Y-24.6%
GM growth 3Y-6.33%
GM growth 5Y-5.11%

4

2. Health

2.1 Basic Checks

AVD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVD has less shares outstanding
Compared to 5 years ago, AVD has less shares outstanding
The debt/assets ratio for AVD is higher compared to a year ago.

2.2 Solvency

AVD has an Altman-Z score of 1.76. This is a bad value and indicates that AVD is not financially healthy and even has some risk of bankruptcy.
AVD has a Altman-Z score (1.76) which is comparable to the rest of the industry.
AVD has a debt to FCF ratio of 3.72. This is a good value and a sign of high solvency as AVD would need 3.72 years to pay back of all of its debts.
AVD has a Debt to FCF ratio of 3.72. This is in the better half of the industry: AVD outperforms 79.52% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that AVD is somewhat dependend on debt financing.
AVD has a Debt to Equity ratio (0.55) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.72
Altman-Z 1.76
ROIC/WACCN/A
WACC9.64%

2.3 Liquidity

A Current Ratio of 1.89 indicates that AVD should not have too much problems paying its short term obligations.
AVD's Current ratio of 1.89 is in line compared to the rest of the industry. AVD outperforms 42.17% of its industry peers.
A Quick Ratio of 0.79 indicates that AVD may have some problems paying its short term obligations.
The Quick ratio of AVD (0.79) is worse than 85.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 0.79

3

3. Growth

3.1 Past

The earnings per share for AVD have decreased strongly by -775.63% in the last year.
The earnings per share for AVD have been decreasing by -20.52% on average. This is quite bad
Looking at the last year, AVD shows a decrease in Revenue. The Revenue has decreased by -2.36% in the last year.
The Revenue has been growing slightly by 4.98% on average over the past years.
EPS 1Y (TTM)-775.63%
EPS 3Y-11.88%
EPS 5Y-20.52%
EPS Q2Q%-9100%
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y8.1%
Revenue growth 5Y4.98%
Sales Q2Q%-20.87%

3.2 Future

Based on estimates for the next years, AVD will show a very strong growth in Earnings Per Share. The EPS will grow by 27.73% on average per year.
Based on estimates for the next years, AVD will show a small growth in Revenue. The Revenue will grow by 0.97% on average per year.
EPS Next Y-375.81%
EPS Next 2Y27.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.18%
Revenue Next 2Y0.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVD. In the last year negative earnings were reported.
AVD is valuated reasonably with a Price/Forward Earnings ratio of 10.25.
Based on the Price/Forward Earnings ratio, AVD is valued cheaper than 81.93% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.99. AVD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVD is valued a bit more expensive than 62.65% of the companies in the same industry.
97.59% of the companies in the same industry are more expensive than AVD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.6
EV/EBITDA 14.52

4.3 Compensation for Growth

A more expensive valuation may be justified as AVD's earnings are expected to grow with 27.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.73%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

AVD has a Yearly Dividend Yield of 2.72%.
Compared to an average industry Dividend Yield of 3.35, AVD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, AVD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.72%

5.2 History

The dividend of AVD is nicely growing with an annual growth rate of 9.54%!
AVD has been paying a dividend for at least 10 years, so it has a reliable track record.
AVD has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.54%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

The earnings of AVD are negative and hence is the payout ratio. AVD will probably not be able to sustain this dividend level.
The dividend of AVD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-11.56%
EPS Next 2Y27.73%
EPS Next 3YN/A

AMERICAN VANGUARD CORP

NYSE:AVD (12/24/2024, 7:56:44 PM)

After market: 4.52 +0.17 (+3.91%)

4.35

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)N/A N/A
Inst Owners82.23%
Inst Owner Change-7.12%
Ins Owners8.81%
Ins Owner Change-4.95%
Market Cap125.24M
Analysts80
Price Target12.75 (193.1%)
Short Float %3.18%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield 2.72%
Dividend Growth(5Y)9.54%
DP-11.56%
Div Incr Years3
Div Non Decr Years3
Ex-Date06-26 2024-06-26 (0.03)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-841.46%
Min EPS beat(2)-858.83%
Max EPS beat(2)-824.09%
EPS beat(4)0
Avg EPS beat(4)-436.85%
Min EPS beat(4)-858.83%
Max EPS beat(4)-11.99%
EPS beat(8)1
Avg EPS beat(8)-245.69%
EPS beat(12)3
Avg EPS beat(12)-161.81%
EPS beat(16)6
Avg EPS beat(16)-114.41%
Revenue beat(2)0
Avg Revenue beat(2)-10.42%
Min Revenue beat(2)-15.85%
Max Revenue beat(2)-4.99%
Revenue beat(4)0
Avg Revenue beat(4)-6.99%
Min Revenue beat(4)-15.85%
Max Revenue beat(4)-1.4%
Revenue beat(8)0
Avg Revenue beat(8)-9.21%
Revenue beat(12)2
Avg Revenue beat(12)-5.2%
Revenue beat(16)5
Avg Revenue beat(16)-2.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-40%
EPS NY rev (1m)-125.4%
EPS NY rev (3m)-125.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.15%
Revenue NY rev (1m)-1.84%
Revenue NY rev (3m)-1.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.25
P/S 0.23
P/FCF 2.6
P/OCF 2.19
P/B 0.38
P/tB 1.09
EV/EBITDA 14.52
EPS(TTM)-1.04
EYN/A
EPS(NY)0.42
Fwd EY9.75%
FCF(TTM)1.67
FCFY38.4%
OCF(TTM)1.99
OCFY45.72%
SpS19.24
BVpS11.39
TBVpS4.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.81%
ROE -8.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.46%
FCFM 8.68%
ROA(3y)2.48%
ROA(5y)2.34%
ROE(3y)4.81%
ROE(5y)4.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.63%
ROCE(5y)5.68%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.8%
OM growth 5Y-13.38%
PM growth 3Y-26.84%
PM growth 5Y-24.6%
GM growth 3Y-6.33%
GM growth 5Y-5.11%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.72
Debt/EBITDA 8.88
Cap/Depr 41.69%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion 284.57%
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 0.79
Altman-Z 1.76
F-Score5
WACC9.64%
ROIC/WACCN/A
Cap/Depr(3y)55.42%
Cap/Depr(5y)62.53%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-775.63%
EPS 3Y-11.88%
EPS 5Y-20.52%
EPS Q2Q%-9100%
EPS Next Y-375.81%
EPS Next 2Y27.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y8.1%
Revenue growth 5Y4.98%
Sales Q2Q%-20.87%
Revenue Next Year-3.18%
Revenue Next 2Y0.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-112.27%
EBIT growth 3Y10.04%
EBIT growth 5Y-9.06%
EBIT Next Year79.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.15%
OCF growth 3YN/A
OCF growth 5YN/A